Researchers pinpoint the exact neurons hit harde
Author: Michael
Early recognition for Behcet’s disease undersc
German biotech launches the first CE-certified P
ImmunoBrain presented Phase 1b results for IBC-Ab
Showing at AD/PD 2026 signals blood-based Alzhei
Origami Therapeutics CEO on harnessing autophagy
New biotech R1 Therapeutics emerges with fresh b
Longevity.
New research connects sustained neurogenesis and
Telehealth platform Wisp launches a new healthy